The prognosis of this disease is poor, the 5-year survival rate after diagnosis is about 50%, 10-year survival rate is about 25%, if early detection and active treatment, the survival period is longer.
1. In the early stage of the disease: if in the early stage of the disease and give timely diagnosis and standardized anti-heart failure treatment, so that the heart function has been improved, so that the symptoms of the disease have been alleviated, can slow down the development of the patient’s condition, the condition of the control of the stabilization of the patient’s survival is greatly prolonged, the survival period can sometimes reach more than 10 years, depending on the patient’s own condition.
2. Failure to find or consult the doctor at an early stage: the patient will have severe heart failure, or serious arrhythmia, in this case, the disease prognosis is usually poor, the patient’s survival time is greatly reduced, or even less than a year, depending on the patient’s own condition progress.
Dilated cardiomyopathy is characterized by heart enlargement, heart failure, arrhythmias, thromboembolism and sudden death. Treatment of the disease is aimed at stopping the underlying cause-mediated myocardial damage, blocking the neurohumoral mechanisms that cause exacerbation of heart failure, removing the triggers for exacerbation of heart failure, controlling arrhythmias and preventing sudden death, preventing complications such as thromboembolism, and improving clinical cardiac function, quality of life, and prolonging survival.
If found to be dilated cardiomyopathy, it is recommended to consult the doctor as soon as possible to avoid delaying the condition.